Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2005-06-28
2005-06-28
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S171000, C514S179000, C514S182000
Reexamination Certificate
active
06911438
ABSTRACT:
The formulation comprises a combination of three estrogens and selected amount of other elements. The three estrogens include 2-hydroxyestrone, 17-beta estradiol, and estriol. The amount of 17-beta estradiol is substantially less than the amounts of 2-hydroxyestrone and estriol, both which are approximately equal in amount. The amounts of pyridoxine, folic acid, selenium and cobalt are therapeutically effective amounts.
REFERENCES:
patent: 6174665 (2001-01-01), Dullien
patent: 6329358 (2001-12-01), Cavazza
patent: 6479545 (2002-11-01), Levinson et al.
patent: 403115222 (1991-05-01), None
patent: 403115222 (1991-05-01), None
patent: WO99/53910 (1999-10-01), None
JP 403115222, Derwent Abstract, Derwent -ACC-No. 1991-188847.
“Textbook of Organic Medicinal and Pharmaceutical Chemistry”, Dwight S. Fullerton et al., 9th edition (Jan. 1991) Lippincott Williams & Wilkins Publishers, p. 691, 694, 698.
Schubert et al., “Hormonsubstitution in der Postmenopause-Auswirkungen auf Spurenelemente und ox. LDL-Antikorper (Substituttion of hormones in the post-menopause effects on trace elements and ox. LDL antibodies)”, 1996, Mengen- Spurenelem, p. 57-63.
CAPLUS abstract, Accession No. 1997:421726, 1996, Schubert et al., p. 1.
Jensen & Puntigam PS
Wang Shengjun
LandOfFree
Hormone replacement formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hormone replacement formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hormone replacement formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3501498